Development of Diabetes Mellitus Type 2 in Stress Hyperglycemia and Control of Known Diabetes Mellitus after Discharge


About this study

The purpose of this study is to determine if Inpatient Stress Hyperglycemia is an indicator of future risk of developing type 2 Diabetes Mellitus.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age 18 years and older, elevated blood sugar, HbA1c measured on admission.

Exclusion Criteria: 

  • Age less than 18
  • Steroid induced hyperglycemia
  • Current pregnancy
  • Recent hospitalization within the last 6 months
  • Terminal illness with expected life expectancy of less than 12 months


Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Steven Smith, M.D.

Closed for enrollment

More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer